Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2021

Feb 24, 2021

32853_dirs_2021-02-23_449acb34-3921-49c2-ba31-f30b802517c7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2021-02-20

Reporting Person: Kreger Bradley Allen (SVP, Global Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-20 Common Stock M 3125 Acquired 33049 Direct
2021-02-20 Common Stock M 2236 Acquired 35285 Direct
2021-02-20 Common Stock M 9562 Acquired 44847 Direct
2021-02-20 Common Stock F 6122 $6.12 Disposed 38725 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-20 Restricted Stock Units $ M 3125 Disposed Common Stock (3125.0) Direct
2021-02-20 Restricted Stock Units $ M 2236 Disposed Common Stock (2236.0) Direct
2021-02-20 Restricted Stock Units $ M 9562 Disposed Common Stock (9562.0) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.